Due to the lapse in government funding, the information on this web site may not be up to date, transactions submitted via the web site may not be processed,
and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government
operating status and resumption of normal operations can be found at opm.gov.
Percentage of Participants Achieving a Serotype-specific Immunoglobulin G (IgG) Antibody Level Greater Than or Equal to (≥) 0.35 Micrograms Per Milliliter (Mcg/mL) Measured 1 Month After the Infant Series
Percentage of Participants Achieving a Serotype-specific IgG Antibody Level ≥0.35 Mcg/mL Measured 1 Month After the Toddler Dose
42 Days to 98 Days (Child)
June 3, 2008
June 28, 2011
January 11, 2011
Pfizer Investigational Site Incheon, Bupyeong-gu, Korea, Republic of
Pfizer Investigational Site Seoul, Jongno-gu, Korea, Republic of
Pfizer Investigational Site Incheon, Jung-gu, Korea, Republic of
(and 3 more...)
† Study has passed its completion date and status has not been verified in more than two years.